Malignancy can be treated by medical procedure, chemotherapy, radiation treatment, hormonal treatment, directed treatment (counting immunotherapy, for example, monoclonal counter acting agent treatment) and engineered lethality. The decision of treatment relies on the area and grade of the tumor and the phase of the infection, just as the general condition of the patient (execution status). Malignant growth genome sequencing helps in figuring out which disease the patient precisely has for deciding the best treatment for the malignancy. Various trial malignancy medicines are likewise being worked on. Under current appraisals, two of every five individuals will have malignancy sooner or later in the course of their life